Prospective evaluation of serum CA 125 levels in a normal population, phase I: The specificities of single and serial determinations in testing for ovarian cancer

Gynecologic Oncology - Tập 36 - Trang 299-305 - 1990
Vincent R. Zurawski1, Kerstin Sjovall2, David A. Schoenfeld3, Susan F. Broderick4, Paul Hall5, Robert C. Bast6, Gunnar Eklund2, Britta Mattsson2, Robert J. Connor7, Philip C. Prorok7, Robert C. Knapp2, Nina Einhorn2
1The Departments of Obstetrics and Gynecology, Gynecological Oncology, and Oncology and Cancer Epidemiology, Radiumhemmet at the Karolinska Hospital, Stockholm, Sweden
2The Department of Obstetrics and Gynecology, Harvard Medical School, the Brigham and Women's Hospital, the Dana-Farber Cancer Institute, and the Harvard School of Public Health, Boston, Massachusetts 02115 USA
3The Massachusetts General Hospital, Boston, Massachusetts 02114 USA
4Centocor, Malvern Pennsylvania 19335 USA
5AMRAB, Sophiahemmet, USA
6the Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710 USA
7The National Cancer Institute, Division of Cancer Prevention and Control, Biometry Branch, Bethesda, Maryland 20892 USA

Tài liệu tham khảo

Pettersson, 1985, 19, 210 Zurawski, 1987, Serum CA 125 levels in a group of nonhospitalized women: Relevance for the early detection of ovarian cancer, Obstet. Gynecol., 69, 606 Bast, 1983, A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer, N. Engl. J. Med., 309, 883, 10.1056/NEJM198310133091503 Bast, 1985, Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma, Gynecol. Oncol., 22, 115, 10.1016/0090-8258(85)90015-0 Zurawski, 1988, Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasms: Relevance for early detection of ovarian cancer, Int. J. Cancer, 42, 677, 10.1002/ijc.2910420507 Mattsson, 1984, Cancer registration in Sweden Klug, 1984, Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas, Cancer Res., 44, 1048 Bolton, 1973, The labeling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent, Biochem. J., 133, 529, 10.1042/bj1330529 Fraker, 1978, Protein and cell membrance iodination with a sparingly soluble chloramide, 1,3,4,6-tetrachloro-3a-6a-diphenylglycouril, Biochem. Biophys. Res. Commun., 80, 849, 10.1016/0006-291X(78)91322-0 Klug, 1988, Confirmation of a false-positive result in CA 125 immunoradiometric assay caused by human anti-idiotypic imunoglobulin, Clin. Chem., 34, 1071, 10.1093/clinchem/34.6.1071 Miller, 1986, 16 Searle, 1971, 443 Barbieri, 1986, Elevated serum concentrations of CA 125 in patients with advanced endometriosis, Fertil. Steril., 45, 630, 10.1016/S0015-0282(16)49333-7 Niloff, 1984, CA 125 antigen levels in obstetric and gynecologic patients, Obstet. Gynecol., 64, 703 Halila, 1986, Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy, Cancer, 57, 1327, 10.1002/1097-0142(19860401)57:7<1327::AID-CNCR2820570713>3.0.CO;2-Z Jacobs, 1988, Multimodal approach to screening for ovarian cancer, Lancet, 1, 168 Finkler, 1988, Comparison of serum CA 125, clinical impression and ultrasound in the preoperative evaluation of ovarian masses, Obstet. Gynecol., 72, 659 Zurawski, 1988, An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma, Gynecol. Oncol., 30, 7, 10.1016/0090-8258(88)90039-X